Calciphylaxis study in kidney disease patients
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a rare condition called calciphylaxis (hardening of small blood vessels) that can happen in people with chronic kidney disease. It aims to learn more about what causes it and how to help those affected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have chronic kidney disease (CKD).
- If you have been diagnosed or are suspected to have calciphylaxis, you may join as a 'case'.
- You must be able to give informed consent and take part in the study.
- If you are in the healthy reference group, you must consider yourself healthy and have normal kidney function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and stores information from people with calciphylaxis, a serious condition that causes painful skin lesions. It may help researchers learn more about the disease and improve future care.
This Phase 3 study is for adults on regular dialysis who have a new calciphylaxis ulcer. It tests a better way to give and use treatment guidance so ulcers may improve with clearer, more consistent care.
This early-phase study tests a stem cell therapy made from amniotic (placenta) tissue for people with calciphylaxis. If you qualify, the goal is to see whether this treatment is safe and potentially helpful for this rare, painful condition.
This trial tests an investigational drug called EPN-701 for people with calciphylaxis, a painful condition that causes skin ulcers and often affects those on dialysis. The study aims to see if the drug can reduce pain and improve the condition.
This study tests a drug called tocilizumab (which calms inflammation) to see if it helps people with calciphylaxis, a painful skin condition linked to kidney disease. The drug might reduce pain and improve healing of skin sores.
This study is a simple screening to check for early signs of chronic kidney disease. It aims to find kidney problems in people who are at higher risk due to age or other health conditions.
Hear when a new Calciphylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.